Exact Mass: 449.1773

Exact Mass Matches: 449.1773

Found 17 metabolites which its exact mass value is equals to given mass value 449.1773, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

N-[2,6-Bis(1-methylethyl)phenyl]-N'-[4-[(4-nitrophenyl)thio]phenyl]urea

N-[2,6-bis(propan-2-yl)phenyl]-N-{4-[(4-nitrophenyl)sulphanyl]phenyl}carbamimidic acid

C25H27N3O3S (449.1773)


   

Cys Cys Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C17H31N5O5S2 (449.1767)


   

Cys Cys Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C17H31N5O5S2 (449.1767)


   

Cys Lys Cys Pro

(2S)-1-[(2R)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C17H31N5O5S2 (449.1767)


   

Cys Lys Pro Cys

(2R)-2-{[(2S)-1-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C17H31N5O5S2 (449.1767)


   

Cys Pro Cys Lys

(2S)-6-amino-2-[(2R)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]hexanoic acid

C17H31N5O5S2 (449.1767)


   

Cys Pro Lys Cys

(2R)-2-[(2S)-6-amino-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}hexanamido]-3-sulfanylpropanoic acid

C17H31N5O5S2 (449.1767)


   

Lys Cys Cys Pro

(2S)-1-[(2R)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C17H31N5O5S2 (449.1767)


   

Lys Cys Pro Cys

(2R)-2-{[(2S)-1-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C17H31N5O5S2 (449.1767)


   

Lys Pro Cys Cys

(2R)-2-[(2R)-2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C17H31N5O5S2 (449.1767)


   

Pro Cys Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]hexanoic acid

C17H31N5O5S2 (449.1767)


   

Pro Cys Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]hexanamido]-3-sulfanylpropanoic acid

C17H31N5O5S2 (449.1767)


   

Pro Lys Cys Cys

(2R)-2-[(2R)-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C17H31N5O5S2 (449.1767)


   

Brexpiprazole S-oxide

Brexpiprazole S-oxide

C25H27N3O3S (449.1773)


   

N-[2,6-Bis(1-methylethyl)phenyl]-N-[4-[(4-nitrophenyl)thio]phenyl]urea

N-[2,6-Bis(1-methylethyl)phenyl]-N-[4-[(4-nitrophenyl)thio]phenyl]urea

C25H27N3O3S (449.1773)


VULM 1457 is a potent inhibitor of cholesterol acyltransferase (acyl-CoA). VULM1457 significantly reduces production and secretion of adrenomedullin (AM) and down-regulates AM receptors on human hepatoblastic cells. VULM 1457 has remarkable hypolipidaemic activity and improves the overall myocardial ischaemia-reperfusion injury outcomes. VULM 1457 has the potential for the research of diabetes mellitus and hypercholesterolaemia[1][2].

   

N-[[4-[oxo-[4-(phenylmethyl)-1-piperazinyl]methyl]phenyl]methyl]benzenesulfonamide

N-[[4-[oxo-[4-(phenylmethyl)-1-piperazinyl]methyl]phenyl]methyl]benzenesulfonamide

C25H27N3O3S (449.1773)


   

N-[3-(3,5-dimethyl-1-pyrazolyl)-2-hydroxypropyl]-N-(4-methylphenyl)-2-naphthalenesulfonamide

N-[3-(3,5-dimethyl-1-pyrazolyl)-2-hydroxypropyl]-N-(4-methylphenyl)-2-naphthalenesulfonamide

C25H27N3O3S (449.1773)